MoneyWorks4Me

Meghmani Finechem informs about investor presentation

11 Nov 2021 Evaluate

Meghmani Finechem has informed that it enclosing a copy of Corporate Announcement Presentation of the Company for information of members. The above presentation is also being placed on the website of the Company at www.meghmanifinechem.com.

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1098.35 -19.05 (-1.70%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2609.10
BASF India 4083.85
Pidilite Inds. 1690.00
Tata Chemicals 670.40
GNFC 568.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: